Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
The Potential Use of Bacteria and Bacterial Derivatives As Drug Delivery Systems for Viral Infection Publisher Pubmed



Faghihkhorasani A1 ; Ahmed HH2 ; Mashool NM3 ; Alwan M4 ; Assefi M5 ; Adab AH6 ; Yasamineh S7 ; Gholizadeh O8 ; Baghani M9
Authors
Show Affiliations
Authors Affiliations
  1. 1. Medical Student, Iran University of Medical Sciences, Tehran, Iran
  2. 2. Department of Pharmacy, Al-Noor University College, Nineveh, Iraq
  3. 3. College of Nursing, National University of Science and Technology, Dhi Qar, Iraq
  4. 4. Pharmacy College, Al-Farahidi University, Baghdad, Iraq
  5. 5. University of North Carolina at Greensboro, Greensboro, United States
  6. 6. Department of Pharmacy, Al-Zahrawi University College, Karbala, Iraq
  7. 7. Young Researchers and Elite Club, Tabriz Branch, Islamic Azad University, Tabriz, Iran
  8. 8. Research Center for Clinical Virology, Tehran University of Medical Sciences, Tehran, Iran
  9. 9. Skin Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran

Source: Virology Journal Published:2023


Abstract

Viral infections in humans are responsible for fatalities worldwide and contribute to the incidence of various human ailments. Controllable targeted medicine delivery against many illnesses, including viral infection, may be significantly aided by using bacteria and bacteria-derived products. They may accumulate in diseased tissues despite physical obstacles, where they can launch antiviral immunity. The ability to genetically and chemically modify them means that vaccinations against viral infections may be manufactured and delivered to affected tissues more safely and effectively. The objective of this study is to provide an overview of the latest advancements in the field of utilizing bacteria and bacterial derivatives as carriers for administering medication to treat viral diseases such as SARS-CoV-2, hepatitis B virus, hepatitis C virus, human immunodeficiency virus, human papillomavirus, influenza, and Ebola virus. Graphical Abstract: [Figure not available: see fulltext.] © 2023, BioMed Central Ltd., part of Springer Nature.
Other Related Docs
16. Decorating and Loading Ghosts With Allergens for Allergen Immunotherapy, Human Vaccines and Immunotherapeutics (2017)
21. A State-Of-The-Art Review on Solid Lipid Nanoparticles As a Nanovaccines Delivery System, Journal of Drug Delivery Science and Technology (2023)
23. Bacteria and Archaea: A New Era of Cancer Therapy, Journal of Controlled Release (2021)